TELMITRAC-H Tablet
Telmitrac 40mg+Hydrochlorothiazide 12.5mg
Indication
*Hypertension
*Cardiovascular risk reductions
Telmitrac +Hydrochlorothiazide:
Possess a long duration of action due to long terminal
elimination half-life of about 24 hours in hypertensive patients.
Shows greater reduction in mean SBP and DBP compared with ramipril after 14 weeks.
Demonstrates superiority in improvement of insulin sensitivity and plasma lipid profile in overweight hypersentivity as compared to eprosartan.